PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24211617-1	2014	Molecular docking studies have shown that Delta(8,14)-anhydrobufalin (1) exhibited more potent binding affinity on androgen receptor (AR) than Delta(14,15)-anhydrobufalin (2) and bufalin (3).	bufalin	61-68	androgen receptor	Homo sapiens	115-132	
32623699-0	2020	Bufalin inhibits hepatitis B virus-associated hepatocellular carcinoma development through androgen receptor dephosphorylation and cell cycle-related kinase degradation.	bufalin	0-7	androgen receptor	Homo sapiens	91-108	
32623699-9	2020	Androgen receptor (AR) signaling was found to be a target of bufalin resistance to HBV-associated hepatocarcinogenesis.	bufalin	61-68	androgen receptor	Homo sapiens	0-17	
30166403-3	2018	In prostate cancer cell models, P53-dependent and independent caspase-mediated apoptosis and androgen receptor (AR) antagonism have been described for bufalin at micromolar concentrations.	bufalin	151-158	androgen receptor	Homo sapiens	93-110	
30166403-3	2018	In prostate cancer cell models, P53-dependent and independent caspase-mediated apoptosis and androgen receptor (AR) antagonism have been described for bufalin at micromolar concentrations.	bufalin	151-158	androgen receptor	Homo sapiens	112-114	
24211617-1	2014	Molecular docking studies have shown that Delta(8,14)-anhydrobufalin (1) exhibited more potent binding affinity on androgen receptor (AR) than Delta(14,15)-anhydrobufalin (2) and bufalin (3).	bufalin	61-68	androgen receptor	Homo sapiens	134-136